Climb Bio Inc.

XNAS:CLYM   4:00:00 PM EDT
8.88
+0.10 (+1.14%)
5:47:51 PM EDT: $9.00 +0.12 (+1.35%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Climb Bio Inc. Stock, XNAS:CLYM

20 William Street, Suite 145, Wellesley Hills, Massachusetts 02481-4103
United States of America
Phone: +1.866.857.2596
Number of Employees: 9
http://www.climbbio.com

Description

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.